Gilead Sciences Aktie
103,16
EUR
+0,06
EUR
+0,06
%
110,55
USD
-1,38
USD
-1,23
%
Werbung
Gilead Sciences Aktie Analyse
23.03.11 | Gilead Sciences buy | UBS AG | |
17.03.11 | Gilead Sciences kaufen | Der Aktionär | |
24.02.11 | Gilead Sciences outperform | RBC Capital Markets | |
18.02.11 | Gilead Sciences kaufen | Der Aktionär | |
26.01.11 | Gilead Sciences outperform | Credit Suisse Group | |
20.01.11 | Gilead Sciences outperform | Credit Suisse Group | |
06.01.11 | Gilead Sciences outperform | Williams Capital | |
07.12.10 | Gilead Sciences outperform | Credit Suisse Group | |
Werbung
|
|||
17.11.10 | Gilead Sciences buy | UBS AG | |
01.11.10 | Gilead Sciences outperform | RBC Capital Markets | |
21.07.10 | Gilead Sciences outperform | Oppenheimer & Co. Inc. | |
04.06.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
04.05.10 | Gilead Sciences kaufen | Morgan Stanley | |
23.04.10 | Gilead Sciences kaufen | Morgan Stanley | |
21.04.10 | Gilead Sciences kaufen | Needham & Company, LLC | |
01.04.10 | Gilead Sciences kaufen | Der Aktionär | |
12.03.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
16.02.10 | Gilead Sciences kaufen | Credit Suisse Group | |
29.01.10 | Gilead Sciences kaufen | boerse.de-Aktienbrief | |
27.01.10 | Gilead Sciences kaufen | Credit Suisse Group | |
15.12.09 | Gilead Sciences outperform | Credit Suisse Group | |
11.12.09 | Gilead Sciences outperform | Credit Suisse Group | |
02.12.09 | Gilead Sciences buy | UBS AG | |
06.11.09 | Gilead Sciences | boerse.de-Aktienbrief | |
21.10.09 | Gilead Sciences outperform | Credit Suisse Group | |
23.07.09 | Gilead Sciences outperform | Wedbush Morgan Securities Inc. | |
22.07.09 | Gilead Sciences outperform | Credit Suisse Group | |
03.07.09 | Gilead Sciences einkaufen | boerse.de-Aktienbrief | |
26.06.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
14.05.09 | Gilead Sciences | Focus Money | |
11.05.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
08.05.09 | Gilead Sciences | boerse.de-Aktienbrief | |
29.04.09 | Gilead Sciences | Der Aktionär | |
22.04.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
22.04.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
15.04.09 | Gilead Sciences buy | ThinkEquity Partners LLC | |
07.04.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
06.04.09 | Gilead Sciences outperform | Credit Suisse Group | |
03.04.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
01.04.09 | Gilead Sciences buy | Citigroup Corp. | |
27.03.09 | Gilead Sciences buy | Citigroup Corp. | |
20.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
19.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
18.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
16.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated | |
13.03.09 | Gilead Sciences outperform | Credit Suisse Group | |
13.03.09 | Gilead Sciences outperform | RBC Capital Markets | |
13.03.09 | Gilead Sciences buy | Wedbush Morgan Securities Inc. | |
13.03.09 | Gilead Sciences buy | Citigroup Corp. | |
12.03.09 | Gilead Sciences outperform | Robert W. Baird & Co. Incorporated |
Werbung
Werbung